Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: Relation to autoantibody status and comparison with Belgian patients

Diabetes Research and Clinical Practice

Volumn 103, Issue 1, 2014, Pages 97-105

  Asanghanwa, Milca ^a   Gorus, Frans K ^a,b   Weets, Ilse ^a,b   der Auwera, Bart V ^a   Aminkeng, Folefac ^c   Mbunwe, Eric ^a   Goubert, Patrick ^b   Verhaeghen, Katrijn ^b   Sobngwi, Eugene ^d   Wenzlau, Janet M ^e   Hutton, John C ^e   Pipeleers, Daniel G ^a   Keymeulen, Bart ^a,b   Mbanya, Jean Claude N ^d   Van Schravendijk, Chris ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoantibodies; Classification; Diabetes; Sub Saharan Africa

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; C PEPTIDE; GLUTAMATE DECARBOXYLASE; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; INSULIN; INSULINOMA ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BELGIUM; BODY MASS; CAMEROON; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KETONURIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RACE DIFFERENCE;

AUTOANTIBODIES; CLASSIFICATION; DIABETES; SUB-SAHARAN AFRICA;

ADOLESCENT; ADULT; AUTOANTIBODIES; BELGIUM; BIOLOGICAL MARKERS; CAMEROON; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; YOUNG ADULT;

EID: 84893640449     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.11.013     Document Type: Article

References (38)

1. International Diabetes Federation Diabetes Atlas 2011, 5th ed.
2. Gill G.V., Mbanya J.C., Ramaiya K.L., Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia 2009, 52:8-16.
3. Ducorps M., Ndong W., Jupkwo B., Belmejdoub G., Thiolet C., Mayaudon H., et al. Diabetes in Cameroon. Classification difficulties in Africa. Med Trop 1996, 56:264-270.
4. Gill G.V., Tekle A., Reja A., Wilie D., English P., Driver M., et al. Immunological and C-peptide studies of patients with diabetes in northern Ethiopia: existence of an unusual subgroup possibly related to malnutrition. Diabetologia 2011, 54:51-57.
5. Campbell R.K. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc (2003) 2009, 49(Suppl. 1):S3-S9.
6. Gorus F.K. Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Belgian Diabetes Registry. Diabetes Metab Rev 1997, 13:247-274.
7. Ostman J., Lernmark A., Landin-Olsson M., Sundkvist G., Palmer J., Arnqvist H., et al. Autoimmune (type 1) diabetes in young adults in Sweden. Horm Metab Res 1996, 28:348-350.
8. Zimmet P.Z. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care 1995, 18:1050-1064.
9. Gorus F.K., Goubert P., Semakula C., Vandewalle C.L., De Schepper J., Scheen A., et al. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia 1997, 40:95-99.
10. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003, 26:3160-3167.
11. Oli J.M., Bottazzo G.F., Doniach D. Islet cell antibodies and diabetes in Nigerians. Trop Geogr Med 1981, 33:161-164.
12. McLarty D.G., Athaide I., Bottazzo G.F., Swai A.M., Alberti K.G. Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans. Diabetes Res Clin Pract 1990, 9:219-224.
13. Lutale J.J., Thordarson H., Holm P.I., Eide G.E., Vetvik K. Islet cell autoantibodies in African patients with type 1 and type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study. J Autoimmune Dis 2007, 4:4.
14. Hawa M.I., Picardi A., Costanza F., D'Avola D., Berreta Anguissola G., Guglielmi C., et al. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon. Clin Immunol 2006, 118:229-232.
15. World Health Organisation Definition, diagnosis and classification of diabetes mellitus and its complications 1999, WHO, Geneva.
16. De Grijse J., Asanghanwa M., Nouthe B., Albrecher N., Goubert P., Vermeulen I., et al. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 2010, 53:517-524.
17. Van der Auwera B., Schuit F., Lyaruu I., Falorni A., Svanholm S., Vandewalle C.L., et al. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. J Clin Endocrinol Metab 1995, 80:2567-2573.
18. Truyen I., De Pauw P., Jorgensen P.N., van Schravendijk C., Ubani O., Decochez K., et al. Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes. Diabetologia 2005, 48:2322-2329.
19. Wenzlau J.M., Liu Y., Yu L., Moua O., Fowler K.T., Rangasamy S., et al. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008, 57:2693-2697.
20. Schleicher E.D., Vogt B.W. Standardization of serum fructosamine assays. Clin Chem 1990, 36:136-139.
21. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27:S5-S10.
22. Vandewalle C.L., Coeckelberghs M.I., De Leeuw I.H., Du Caju M.V., Schuit F.C., Pipeleers D.G., et al. Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry. Diabetes Care 1997, 20:1556-1561.
23. Vermeulen I., Weets I., Asanghanwa M., Ruije J., Van Gaal L., Mathieu C., et al. Contribution of antibodies against IA-2ß and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care 2011, 34:1760-1765.
24. Decochez K., Tits J., Coolens J.L., Van Gaal L., Krzentowski G., Winnock F., et al. High frequency of persistent or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. Diabetes Care 2000, 23:838-844.
25. Swai A.B.M., Lutale J.L., McLarty D.G. Prospective study of incidence of juvenile diabetes mellitus over 10 years in Dar es Salaam, Tanzania. BMJ 1993, 306:1570-1572.
26. Maldonado M., Hampe C.S., Gaur L.K., D'Amico S., Iyer D., Hammerle L.P., et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using and immunogenetic and ß-cell functional classification, prospective analysis and clinical outcomes. J Clin Endocrinol Metab 2003, 88:5090-5098.
27. Tuomi T. Type 1 and type 2 diabetes. What do they have in commonα. Diabetes 2005, 54(Suppl. 2):S40-S45.
28. Bingley P.J., Bonifacio E., Gale E.A. Can we really predict IDDM. Diabetes 1993, 42:213-220.
29. Yongsoo P. Why is type 1 diabetes uncommon in Asia. Ann N Y Acad Sci 2006, 1079:31-40.
30. Choukem S.P., Sobngwi E., Boudou P., Fetita L.S., Porcher R., Ibrahim F., et al. β- and α-cell dysfunctions in Africans with ketosis-prone atypical diabetes during near normoglycaemic remission. Diabetes Care 2003, 36(1):118-123.
31. Mauvais-Jarvis F., Sobngwi E., Porcher R., Riveline J.P., Kevorkian J.P., Vaisse C., et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance. Diabetes 2004, 53:645-653.
32. + ketosis-prone diabetes. Diabetes 2013, 62:912-922.
33. Mauvais-Jarvis F., Smith S.B., le May C., Leal S.M., Gautier J.F., Molokhia M., et al. Pax4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet 2004, 13:3151-3159.
34. Thunander M., Torn C., Petersson C., Ossianson B., Fornander J., Landin-Olsson M. Levels of C-peptide, body mass index and age, and their usefulness in classification of autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden. Eur J Endocrinol 2012, 166:1021-1029.
35. Törn C., Landin-Olsson M., Scherstéin B. Predictability of C-peptide for autoimmune diabetes in young adult diabetic patients. Pract Diabetes Int 2001, 18:83-88.
36. Abdelaziz E., Omer M., Ibrahim A., Tuvemo T. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children. Diabetes Res Clin Pract 1992, 16:91-96.
37. Peters W.H., Lester F.T., Kohnert K.D., Hildmann W. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia. Exp Clin Endocrinol 1986, 87:326-332.
38. Asanghanwa M., van Genderen F., Verhaeghen K., Van der Auwera B., Sobngwi E., Mbanya J.C., et al. Validation of an enzyme-linked immunosorbent assay for C-peptide analysis in Cameroon. Diabetes Res Clin Pract 2012, 98:459-464.